Antibiotic + Steroid — a detailed guide to composition, benefits, and use.
Tobramycin and Fluorometholone ophthalmic suspension for simultaneous bacterial infection control and inflammation suppression in ocular surface disease.
F.M.T. Ophthalmic Suspension combines Tobramycin 0.3% (a bactericidal aminoglycoside) with Fluorometholone 0.1% (a moderately potent corticosteroid) in a stabilized suspension formulation. This combination addresses the dual challenge of bacterial infection and inflammatory response commonly seen in ocular surface diseases, post-surgical recovery, and complicated anterior segment conditions. Fluorometholone was selected for its favorable safety profile, demonstrating lower IOP elevation risk compared to prednisolone or dexamethasone while still providing effective anti-inflammatory coverage.
| Composition | Tobramycin 0.3% + Fluorometholone 0.1% |
| Volume | 5 mL per bottle |
| pH Range | 6.5 - 7.4 |
| Dosage Form | Ophthalmic suspension |
| Storage | Store at room temperature (15-30°C). Shake well before use. |
| Shelf Life | 24 months from date of manufacture |
| Packaging | 5 mL sterile ophthalmic suspension bottle |
| Dosage | 1 drop in the affected eye(s) 3-4 times daily for 7-14 days, tapering as directed by physician |
Explore the complete product page for packaging, dosing, and enquiry options.
View F.M.T. Ophthalmic Suspension Enquire NowDiscover more insights on eye health and ophthalmic care.